42
Views
36
CrossRef citations to date
0
Altmetric
Research Article

Increased vasodilatory prostaglandin production in the diabetic rat retinal vasculature

, &
Pages 79-82 | Published online: 02 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (7)

Karanvir S. Raman & Joanne A. Matsubara. (2022) Dysregulation of the NLRP3 Inflammasome in Diabetic Retinopathy and Potential Therapeutic Targets. Ocular Immunology and Inflammation 30:2, pages 470-478.
Read now
Francesco Semeraro, Andrea Russo, Elena Gambicorti, Sarah Duse, Francesco Morescalchi, Sara Vezzoli & Ciro Costagliola. (2015) Efficacy and vitreous levels of topical NSAIDs. Expert Opinion on Drug Delivery 12:11, pages 1767-1782.
Read now
Ester Carreño, Alejandro Portero, David J Galarreta & José M Herreras. (2012) Update on twice-daily bromfenac sodium sesquihydrate to treat postoperative ocular inflammation following cataract extraction. Clinical Ophthalmology 6, pages 637-644.
Read now
Laurence S Lim & Tien Y Wong. (2012) Lipids and diabetic retinopathy. Expert Opinion on Biological Therapy 12:1, pages 93-105.
Read now
Carol Toris & Vikas Gulati. (2011) The biology, pathology and therapeutic use of prostaglandins in the eye. Clinical Lipidology 6:5, pages 577-591.
Read now
Wenbo Zhang, Hua Liu, Modesto Rojas, Robert W Caldwell & Ruth B Caldwell. (2011) Anti-Inflammatory Therapy for Diabetic Retinopathy. Immunotherapy 3:5, pages 609-628.
Read now
Tim M Curtis, Alan W Stitt, Mary K McGahon, C Norman Scholfield & J Graham McGeown. (2007) New developments in diabetic retinopathy. Expert Review of Ophthalmology 2:6, pages 947-956.
Read now

Articles from other publishers (29)

Yue Yuan, Meiyuan Dong, Song Wen, Xinlu Yuan & Ligang Zhou. (2024) Retinal microcirculation: A window into systemic circulation and metabolic disease. Experimental Eye Research 242, pages 109885.
Crossref
Arpon BiswasAbhijit Deb ChoudhurySristi AgrawalAmol Chhatrapati BisenSachin Nashik SanapSarvesh Kumar VermaMukesh KumarAnjali MishraShivansh KumarMridula ChauhanRabi Sankar Bhatta. (2024) Recent Insights into the Etiopathogenesis of Diabetic Retinopathy and Its Management. Journal of Ocular Pharmacology and Therapeutics 40:1, pages 13-33.
Crossref
Weiye Li & Jingfa Zhang. 2024. Therapeutic Targets for Diabetic Retinopathy. Therapeutic Targets for Diabetic Retinopathy 113 143 .
Brice Nguedia Vofo & Itay Chowers. (2023) Suppressing Inflammation for the Treatment of Diabetic Retinopathy and Age-Related Macular Degeneration: Dazdotuftide as a Potential New Multitarget Therapeutic Candidate. Biomedicines 11:6, pages 1562.
Crossref
Karolina Kot, Daria Kołodziej, Patrycja Kupnicka, Danuta Izabela Kosik-Bogacka & Natalia Łanocha-Arendarczyk. (2022) Concentrations of PGE2 and TXB2 in the Eyes of Mice with Disseminated Acanthamoebiasis. Pathogens 11:4, pages 438.
Crossref
Chen Chen, Chenguang Wang, Xuebin Zhou, Lingxian Xu, Han Chen, Kun Qian, Bo Jia, Guanfang Su & Jinling Fu. (2021) Nonsteroidal anti-inflammatory drugs for retinal neurodegenerative diseases. Prostaglandins & Other Lipid Mediators 156, pages 106578.
Crossref
Priscilla Peixi Choo, Norshamsiah Md Din, Nooraniah Azmi & Mae-Lynn Catherine Bastion. (2021) Review of the management of sight-threatening diabetic retinopathy during pregnancy. World Journal of Diabetes 12:9, pages 1386-1400.
Crossref
William S. Wright, Randa S. Eshaq, Minsup Lee, Gaganpreet Kaur & Norman R. Harris. 2011. Comprehensive Physiology. Comprehensive Physiology 933 974 .
F. Semeraro, F. Morescalchi, A. Cancarini, A. Russo, S. Rezzola & C. Costagliola. (2019) Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications. Diabetes & Metabolism 45:6, pages 517-527.
Crossref
Megan E. Capozzi, Sandra S. Hammer, Gary W. McCollum & John S. Penn. (2016) Epoxygenated Fatty Acids Inhibit Retinal Vascular Inflammation. Scientific Reports 6:1.
Crossref
Rania Nasrallah, Ramzi Hassouneh & Richard L. Hébert. (2016) PGE2, Kidney Disease, and Cardiovascular Risk. Journal of the American Society of Nephrology 27:3, pages 666-676.
Crossref
Line Petersen & Toke Bek. (2016) Preserved Pressure Autoregulation but Disturbed Cyclo-Oxygenase and Nitric Oxide Effects on Retinal Arterioles during Acute Hypoxia in Diabetic Patients without Retinopathy. Ophthalmologica 235:2, pages 114-120.
Crossref
Menakshi Bhat, Mylène Pouliot, Réjean Couture & Elvire Vaucher. 2014. Recent Developments in the Regulation of Kinins. Recent Developments in the Regulation of Kinins 111 143 .
Mohammed Mostafa Ibrahim, Abd-Elgawad Helmy Abd-Elgawad, Osama Abd-Elazeem Soliman & Monica M. Jablonski. (2013) Pharmaceutical Nanotechnology Nanoparticle-Based Topical Ophthalmic Formulations for Sustained Celecoxib Release. Journal of Pharmaceutical Sciences 102:3, pages 1036-1053.
Crossref
Mohammed Mostafa Ibrahim, Abd-Elgawad Helmy Abd-Elgawad, Osama Abd-Elazeem Soliman & Monica M Jablonski. (2013) Natural bioadhesive biodegradable nanoparticles-based topical ophthalmic formulations for sustained celecoxib release: in vitro study. journal of Pharmaceutical Technology and Drug Research 2:1, pages 7.
Crossref
Andrea Russo, Ciro Costagliola, Luisa Delcassi, Francesco Parmeggiani, Mario R. Romano, Roberto dell'Omo & Francesco Semeraro. (2013) Topical Nonsteroidal Anti-Inflammatory Drugs for Macular Edema. Mediators of Inflammation 2013, pages 1-11.
Crossref
Scott D. Schoenberger & Stephen J. Kim. (2013) Nonsteroidal Anti-Inflammatory Drugs for Retinal Disease. International Journal of Inflammation 2013, pages 1-8.
Crossref
Golnaz Javey, Stephen G. Schwartz & Harry W. Flynn. (2012) Emerging Pharmacotherapies for Diabetic Macular Edema. Experimental Diabetes Research 2012, pages 1-12.
Crossref
EMILY Y. CHEW, JONGHYEON KIM, HANNA R. COLEMAN, LLOYD PAUL AIELLO, GARY FISH, MICHAEL IP, JULIA A. HALLER, MARIA FIGUEROA, DANIEL MARTIN, DAVID CALLANAN, ROBERT AVERY, KERI HAMMEL, DARBY J. S. THOMPSON & FREDERICK L. FERRIS. (2010) PRELIMINARY ASSESSMENT OF CELECOXIB AND MICRODIODE PULSE LASER TREATMENT OF DIABETIC MACULAR EDEMA. Retina 30:3, pages 459-467.
Crossref
Stephen J. Kim, Allan J. Flach & Lee M. Jampol. (2010) Nonsteroidal Anti-inflammatory Drugs in Ophthalmology. Survey of Ophthalmology 55:2, pages 108-133.
Crossref
Heping Xu, Mei Chen & John V. Forrester. (2009) Para-inflammation in the aging retina. Progress in Retinal and Eye Research 28:5, pages 348-368.
Crossref
Renu A. Kowluru & Pooi-See Chan. 2008. Diabetic Retinopathy. Diabetic Retinopathy 265 282 .
Timothy S. Kern. (2007) Contributions of Inflammatory Processes to the Development of the Early Stages of Diabetic Retinopathy. Experimental Diabetes Research 2007, pages 1-14.
Crossref
John Paul SanGiovanni & Emily Y. Chew. (2005) The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Progress in Retinal and Eye Research 24:1, pages 87-138.
Crossref
Surya P. Ayalasomayajula, Aniruddha C. Amrite & Uday B. Kompella. (2004) Inhibition of cyclooxygenase-2, but not cyclooxygenase-1, reduces prostaglandin E2 secretion from diabetic rat retinas. European Journal of Pharmacology 498:1-3, pages 275-278.
Crossref
T. M. Curtis & C. N. Scholfield. (2004) The role of lipids and protein kinase Cs in the pathogenesis of diabetic retinopathy. Diabetes/Metabolism Research and Reviews 20:1, pages 28-43.
Crossref
Surya P. Ayalasomayajula & Uday B. Kompella. (2003) Celecoxib, a selective cyclooxygenase-2 inhibitor, inhibits retinal vascular endothelial growth factor expression and vascular leakage in a streptozotocin-induced diabetic rat model. European Journal of Pharmacology 458:3, pages 283-289.
Crossref
Karin Conde‐Knape. (2001) Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications. Diabetes/Metabolism Research and Reviews 17:6, pages 412-421.
Crossref
Marjorie E. Dunlop & Evelyne E. Muggli. (2000) Small heat shock protein alteration provides a mechanism to reduce mesangial cell contractility in diabetes and oxidative stress. Kidney International 57:2, pages 464-475.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.